We provide you with 20 years of free, institutional-grade data for ACHV stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ACHV. Explore the full financial landscape of ACHV stock.
| Reported Date | CIK | Ticker | Type |
|---|
Achieve Life Sciences, Inc(NASDAQ:ACHV) 
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in...
Website: http://www.achievelifesciences.com
Founded: 1991
Full Time Employees: 14
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about ACHV stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.